Dendritic cells: A spot on sialic acid

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Crespo, Hélio J ^a,b   Lau, Joseph T Y ^b   Videira, Paula A ^a  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Dendritic cell; Host pathogen interaction; Lectins; Sialic acid; Sialylation

Indexed keywords

EID: 84892173112     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00491     Document Type: Review

References (150)

1. Collin M, Bigley V, Haniffa M, Hambleton S. Human dendritic cell deficiency: the missing ID? Nat Rev Immunol (2011) 11:575-83. doi:10.1038/nri3046
2. Bax M, Garcia-Vallejo JJ, Jang-Lee J, North SJ, Gilmartin TJ, Hernandez G, et al. Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins. J Immunol (2007) 179:8216-24.
3. Crespo HJ, Cabral MG, Teixeira AV, Lau JTY, Trindade H, Videira PA. Effect of sialic acid loss on dendritic cell maturation. Immunology (2009) 128:e621-31. doi:10.1111/j.1365-2567.2009.03047.x
4. Videira PA, Amado IF, Crespo HJ, Alguero MC, Dall'Olio F, Cabral MG, et al. Surface alpha 2-3-and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J (2008) 25:259-68. doi:10.1007/s10719-007-9092-6
5. Harwood NE, Batista FD. Antigen presentation to B cells. F1000 Biol Rep (2010) 2:87. doi:10.3410/B2-87
6. Palucka K, Banchereau J. How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr Opin Immunol (2002) 14:420-31. doi:10.1016/S0952-7915(02)00365-5
7. Qi H, Egen JG, Huang AY, Germain RN. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science (2006) 312:1672-6. doi:10.1126/science.1125703
8. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol (2007) 7:19-30. doi:10.1038/nri1996
9. D'Amico A, Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med (2003) 198:293-303. doi:10.1084/jem.20030107
10. Ishikawa F, Niiro H, Iino T, Yoshida S, Saito N, Onohara S, et al. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood (2007) 110:3591-660. doi:10.1182/blood-2007-02-071613
11. Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood (2001) 97:3333-41. doi:10.1182/blood.V97.11.3333
12. Shigematsu H, Reizis B, Iwasaki H, Mizuno S, Hu D, Traver D, et al. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity (2004) 21:43-53. doi:10.1016/j.immuni.2004.06.011
13. Singh P, Hoggatt J, Hu P, Speth JM, Fukuda S, Breyer RM, et al. Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells. Blood (2012) 119:1671-82. doi:10.1182/blood-2011-03-342428
14. Watowich SS, Liu YJ. Mechanisms regulating dendritic cell specification and development. Immunol Rev (2010) 238:76-92. doi:10.1111/j.1600-065X.2010.00949.x
15. Schraml BU, van Blijswijk J, Zelenay S, Whitney PG, Filby A, Acton SE, et al. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell (2013) 154:843-58. doi:10.1016/j.cell.2013.07.014
16. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med (1997) 185:1101-11. doi:10.1084/jem.185.6.1101
17. O'Keeffe M, Hochrein H, Vremec D, Caminschi I, Miller JL, Anders EM, et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J Exp Med (2002) 196:1307-19. doi:10.1084/jem.20021031
18. Segura E, Amigorena S. Inflammatory dendritic cells in mice and humans. Trends Immunol (2013) 34(9):440-5. doi:10.1016/j.it.2013.06.001
19. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med (1995) 182:389-400. doi:10.1084/jem.182.2.389
20. Norbury CC. Drinking a lot is good for dendritic cells. Immunology (2006) 117:443-51. doi:10.1111/j.1365-2567.2006.02335.x
21. Wilson NS, El-Sukkari D, Belz GT, Smith CM, Steptoe RJ, Heath WR, et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood (2003) 102:2187-94. doi:10.1182/blood-2003-02-0513
22. Kramer A, Bekeschus S, Broker BM, Schleibinger H, Razavi B, Assadian O. Maintaining health by balancing microbial exposure and prevention of infection: the hygiene hypothesis versus the hypothesis of early immune challenge. J Hosp Infect (2013) 83(Suppl 1):S29-34. doi:10.1016/S0195-6701(13)60007-9
23. Rook GA. Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology (2009) 126:3-11. doi:10.1111/j.1365-2567.2008.03007.x
24. Rook GA. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the "hygiene" or "old friends" hypothesis. Clin Exp Immunol (2010) 160:70-9. doi:10.1111/j.1365-2249.2010.04133.x
25. Thomas R, Lipsky PE. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol (1994) 153:4016-28.
26. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med (1994) 179:1109-18. doi:10.1084/jem.179.4.1109
27. Bonasio R, von Andrian UH. Generation, migration and function of circulating dendritic cells. Curr Opin Immunol (2006) 18:503-11. doi:10.1016/j.coi.2006.05.011
28. Forster R, Braun A, Worbs T. Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol (2012) 33:271-80. doi:10.1016/j.it.2012.02.007
29. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol (2003) 3:867-78. doi:10.1038/nri1222
30. Netea MG, van der Graaf C, Van der Meer JW, Kullberg BJ. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J Leukoc Biol (2004) 75:749-55. doi:10.1189/jlb.1103543
31. Schnare M, Holt AC, Takeda K, Akira S, Medzhitov R. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr Biol (2000) 10:1139-42. doi:10.1016/S0960-9822(00)00700-4
32. Dzopalic T, Rajkovic I, Dragicevic A, Colic M. The response of human dendritic cells to co-ligation of pattern-recognition receptors. Immunol Res (2012) 52:20-33. doi:10.1007/s12026-012-8279-5
33. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol (2003) 21:335-76. doi:10.1146/annurev.immunol.21.120601.141126
34. Zelensky AN, Gready JE. The C-type lectin-like domain superfamily. FEBS J (2005) 272:6179-217. doi:10.1111/j.1742-4658.2005.05031.x
35. van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol (2008) 9:593-601. doi:10.1038/ni.f.203
36. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med (2004) 10:475-80. doi:10.1038/nm1039
37. van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB, van Kooyk Y. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res (2005) 65:5935-44. doi:10.1158/0008-5472.CAN-04-4140
38. van Kooyk Y. C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans (2008) 36:1478-81. doi:10.1042/BST0361478
39. van Kooyk Y, Engering A, Lekkerkerker AN, Ludwig IS, Geijtenbeek TB. Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curr Opin Immunol (2004) 16:488-93. doi:10.1016/j.coi.2004.05.010
40. Crocker PR. Siglecs in innate immunity. Curr Opin Pharmacol (2005) 5:431-7. doi:10.1016/j.coph.2005.03.003
41. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol (2007) 7:255-66. doi:10.1038/nri2056
42. Kawasaki N, Vela JL, Nycholat CM, Rademacher C, Khurana A, van Rooijen N, et al. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation. Proc Natl Acad Sci U S A (2013) 110:7826-31. doi:10.1073/pnas.1219888110
43. Lock K, Zhang J, Lu J, Lee SH, Crocker PR. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology (2004) 209:199-207. doi:10.1016/j.imbio.2004.04.007
44. Ben Nasr A, Haithcoat J, Masterson JE, Gunn JS, Eaves-Pyles T, Klimpel GR. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J Leukoc Biol (2006) 80:774-86. doi:10.1189/jlb.1205755
45. Sedlik C, Orbach D, Veron P, Schweighoffer E, Colucci F, Gamberale R, et al. A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. J Immunol (2003) 170:846-52.
46. Caminschi I, Shortman K. Boosting antibody responses by targeting antigens to dendritic cells. Trends Immunol (2012) 33:71-7. doi:10.1016/j.it.2011.10.007
47. Matos I, Mizenina O, Lubkin A, Steinman RM, Idoyaga J. Targeting antigens to dendritic cells in vivo induces protective immunity. PLoS One (2013) 8:e67453. doi:10.1371/journal.pone.0067453
48. Mintern JD, Percival C, Kamphuis MM, Chin WJ, Caruso F, Johnston AP. Targeting dendritic cells: the role of specific receptors in the internalization of polymer capsules. Adv Healthc Mater (2013) 2:940-4. doi:10.1002/adhm.201200441
49. Phanse Y, Carrillo-Conde BR, Ramer-Tait AE, Roychoudhury R, Pohl NLB, Narasimhan B, et al. Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells. Acta Biomater (2013) 9, 8902-9. doi:10.1016/j.actbio.2013.06.024
50. Yao Y, Chen L, Wei W, Deng X, Ma L, Hao S. Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities. Biochem Biophys Res Commun (2013) 436:60-5. doi:10.1016/j.bbrc.2013.05.058
51. Cao J, Jin Y, Li W, Zhang B, He Y, Liu H, et al. DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice. BMC Immunol (2013) 14:39. doi:10.1186/1471-2172-14-39
52. Liechtenstein T, Perez-Janices N, Bricogne C, Lanna A, Dufait I, Goyvaerts C, et al. Immune modulation by genetic modification of dendritic cells with lentiviral vectors. Virus Res (2013) 176:1-15. doi:10.1016/j.virusres.2013.05.007
53. Banerjee DK. N-glycans in cell survival and death: cross-talk between glycosyltransferases. Biochim Biophys Acta (2012) 1820:1338-46. doi:10.1016/j.bbagen.2012.01.013
54. Cabral MG, Piteira AR, Silva Z, Ligeiro D, Brossmer R, Videira PA. Human dendritic cells contain cell surface sialyltransferase activity. Immunol Lett (2010) 131:89-96. doi:10.1016/j.imlet.2010.02.009
55. Hennet T. Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim Biophys Acta (2012) 1820:1306-17. doi:10.1016/j.bbagen.2012.02.001
56. Rosnoblet C, Peanne R, Legrand D, Foulquier F. Glycosylation disorders of membrane trafficking. Glycoconj J (2013) 30:23-31. doi:10.1007/s10719-012-9389-y
57. Varki NM, Varki A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest (2007) 87:851-7. doi:10.1038/labinvest.3700656
58. Sonnenburg JL, Altheide TK, Varki A. A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor. Glycobiology (2004) 14:339-46. doi:10.1093/glycob/cwh039
59. Jones MB, Nasirikenari M, Feng L, Migliore MT, Choi KS, Kazim L, et al. Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis. J Biol Chem (2010) 285:25009-17. doi:10.1074/jbc.M110.104406
60. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie (2001) 83:727-37. doi:10.1016/S0300-9084(01)01301-3
61. Miyagi T, Takahashi K, Hata K, Shiozaki K, Yamaguchi K. Sialidase significance for cancer progression. Glycoconj J (2012) 29:567-77. doi:10.1007/s10719-012-9394-1
62. Stamatos NM, Carubelli I, van de Vlekkert D, Bonten EJ, Papini N, Feng C, et al. LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity. J Leukoc Biol (2010) 88:1227-39. doi:10.1189/jlb.1209776
63. Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci (2012) 1253:16-36. doi:10.1111/j.1749-6632.2012.06517.x
64. Jamieson JC, McCaffrey G, Harder PG. Sialyltransferase: a novel acute-phase reactant. Comp Biochem Physiol B (1993) 105:29-33.
65. Jamieson JC, Lammers G, Janzen R, Woloski BM. The acute phase response to inflammation: the role of monokines in changes in liver glycoproteins and enzymes of glycoprotein metabolism. Comp Biochem Physiol B (1987) 87:11-5.
66. Kaplan HA, Woloski BM, Hellman M, Jamieson JC. Studies on the effect of inflammation on rat liver and serum sialyltransferase. Evidence that inflammation causes release of Gal beta 1 leads to 4GlcNAc alpha 2 leads to 6 sialyltransferase from liver. J Biol Chem (1983) 258:11505-9.
67. Yasukawa Z, Sato C, Kitajima K. Inflammation-dependent changes in alpha2,3-, alpha2,6-, and alpha2,8-sialic acid glycotopes on serum glycoproteins in mice. Glycobiology (2005) 15:827-37. doi:10.1093/glycob/cwi068
68. Zhuo Y, Bellis SL. Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function. J Biol Chem (2011) 286:5935-41. doi:10.1074/jbc.R110.191429
69. Erbacher A, Gieseke F, Handgretinger R, Müller I. Dendritic cells: functional aspects of glycosylation and lectins. Hum Immunol (2009) 70:308-12. doi:10.1016/j.humimm.2009.02.005
70. Hsu DK, Yang RY, Liu FT. Galectins in apoptosis. Methods Enzymol (2006) 417:256-73. doi:10.1016/S0076-6879(06)17018-4
71. Hughes RC. Galectins as modulators of cell adhesion. Biochimie (2001) 83:667-76. doi:10.1016/S0300-9084(01)01289-5
72. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F. Introduction to galectins. Glycoconj J (2004) 19:433-40. doi:10.1023/B:GLYC.0000014072.34840.04
73. Nakahara S, Raz A. On the role of galectins in signal transduction. Methods Enzymol (2006) 417:273-89. doi:10.1016/S0076-6879(06)17019-6
74. Freire-de-Lima L, Oliveira IA, Neves JL, Penha LL, Alisson-Silva F, Dias WB, et al. Sialic acid: a sweet swing between mammalian host and Trypanosoma cruzi. Front Immunol (2012) 3:356. doi:10.3389/fimmu.2012.00356
75. Paris G, Ratier L, Amaya MF, Nguyen T, Alzari PM, Frasch AC. A sialidase mutant displaying trans-sialidase activity. J Mol Biol (2005) 345:923-34. doi:10.1016/j.jmb.2004.09.031
76. Sperandio M. Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J (2006) 273:4377-89. doi:10.1111/j.1742-4658.2006.05437.x
77. Pillai S, Netravali IA, Cariappa A, Mattoo H. Siglecs and immune regulation. Annu Rev Immunol (2012) 30:357-92. doi:10.1146/annurev-immunol-020711-075018
78. Crocker PR, Redelinghuys P. Siglecs as positive and negative regulators of the immune system. Biochem Soc Trans (2008) 36:1467-71. doi:10.1042/BST0361467
79. Liu Y, Chen GY, Zheng P. CD24-Siglec G/10 discriminates danger-from pathogen-associated molecular patterns. Trends Immunol (2009) 30:557-61. doi:10.1016/j.it.2009.09.006
80. Hennet T, Chui D, Paulson JC, Marth JD. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci U S A (1998) 95:4504-9. doi:10.1073/pnas.95.8.4504
81. Moody AM, North SJ, Reinhold B, Van Dyken SJ, Rogers ME, Panico M, et al. Sialic acid capping of CD8beta core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. J Biol Chem (2003) 278:7240-6. doi:10.1074/jbc.M210468200
82. Priatel JJ, Chui D, Hiraoka N, Simmons CJ, Richardson KB, Page DM, et al. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity (2000) 12:273-83. doi:10.1016/S1074-7613(00)80180-6
83. Powell LD, Sgroi D, Sjoberg ER, Stamenkovic I, Varki A. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J Biol Chem (1993) 268:7019-27.
84. Ghosh S, Bandulet C, Nitschke L. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids. Int Immunol (2006) 18:603-11. doi:10.1093/intimm/dxh402
85. Nasirikenari M, Chandrasekaran EV, Matta KL, Segal BH, Bogner PN, Lugade AA, et al. Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation. J Leukoc Biol (2010) 87:457-66. doi:10.1189/jlb.1108704
86. Nasirikenari M, Segal BH, Ostberg JR, Urbasic A, Lau JT. Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood (2006) 108:3397-405. doi:10.1182/blood-2006-04-014779
87. Steinman RM, Adams JC, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J Exp Med (1975) 141:804-20.
88. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 137:1142-62. doi:10.1084/jem.137.5.1142
89. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med (1974) 139:380-97. doi:10.1084/jem.139.2.380
90. Steinman RM, Lustig DS, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. III. Functional properties in vivo. J Exp Med (1974) 139:1431-45. doi:10.1084/jem.139.6.1431
91. Steinman RM, Witmer MD. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci U S A (1978) 75:5132-6. doi:10.1073/pnas.75.10.5132
92. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 223:77-92. doi:10.1016/S0022-1759(98)00204-X
93. Jenner J, Kerst G, Handgretinger R, Muller I. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells. Exp Hematol (2006) 34:1212-8. doi:10.1016/j.exphem.2006.04.016
94. Trottein F, Schaffer L, Ivanov S, Paget C, Vendeville C, Cazet A, et al. Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages. Glycoconj J (2009) 26:1259-74. doi:10.1007/s10719-009-9244-y
95. Hemont C, Neel A, Heslan M, Braudeau C, Josien R. Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness. J Leukoc Biol (2013) 93:599-609. doi:10.1189/jlb.0912452
96. Crocker PR, McMillan SJ, Richards HE. CD33-related siglecs as potential modulators of inflammatory responses. Ann N Y Acad Sci (2012) 1253:102-11. doi:10.1111/j.1749-6632.2011.06449.x
97. Freeman SD, Kelm S, Barber EK, Crocker PR. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood (1995) 85:2005-12.
98. Crocker PR. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr Opin Struct Biol (2002) 12:609-15. doi:10.1016/S0959-440X(02)00375-5
99. Santos L, Draves KE, Boton M, Grewal PK, Marth JD, Clark EA. Dendritic cell-dependent inhibition of B cell proliferation requires CD22. J Immunol (2008) 180:4561-9.
100. Chen GY, Tang J, Zheng P, Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science (2009) 323:1722-5. doi:10.1126/science.1168988
101. Bax M, Kuijf ML, Heikema AP, van Rijs W, Bruijns SC, Garcia-Vallejo JJ, et al. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect Immun (2011) 79:2681-9. doi:10.1128/IAI.00009-11
102. Avril T, Attrill H, Zhang J, Raper A, Crocker PR. Negative regulation of leucocyte functions by CD33-related siglecs. Biochem Soc Trans (2006) 34:1024-7. doi:10.1042/BST0341024
103. Carlin AF, Lewis AL, Varki A, Nizet V. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J Bacteriol (2007) 189:1231-7. doi:10.1128/JB.01155-06
104. Jones C, Virji M, Crocker PR. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol Microbiol (2003) 49:1213-25. doi:10.1046/j.1365-2958.2003.03634.x
105. Khatua B, Ghoshal A, Bhattacharya K, Mandal C, Saha B, Crocker PR. Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition. FEBS Lett (2010) 584:555-61. doi:10.1016/j.febslet.2009.11.087
106. Biedermann B, Gil D, Bowen DT, Crocker PR. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors. Leuk Res (2007) 31:211-20. doi:10.1016/j.leukres.2006.05.026
107. Izquierdo-Useros N, Lorizate M, Puertas MC, Rodriguez-Plata MT, Zangger N, Erikson E, et al. Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol (2012) 10:e1001448. doi:10.1371/journal.pbio.1001448
108. Severi E, Hood DW, Thomas GH. Sialic acid utilization by bacterial pathogens. Microbiology (2007) 153:2817-22. doi:10.1099/mic.0.2007/009480-0
109. Lim JP, Gleeson PA. Macropinocytosis: an endocytic pathway for internalising large gulps. Immunol Cell Biol (2011) 89:836-43. doi:10.1038/icb.2011.20
110. Nayak JV, Hokey DA, Larregina A, He Y, Salter RD, Watkins SC, et al. Phagocytosis induces lysosome remodeling and regulated presentation of particulate antigens by activated dendritic cells. J Immunol (2006) 177:8493-503.
111. Cabral MG, Silva Z, Ligeiro D, Seixas E, Crespo H, Carrascal MA, et al. The phagocytic capacity and immunological potency of human dendritic cells is improved by α2,6-sialic acid deficiency. Immunology (2013) 138:235-45. doi:10.1111/imm.12025
112. Garrett WS, Chen LM, Kroschewski R, Ebersold M, Turley S, Trombetta S, et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell (2000) 102:325-34. doi:10.1016/S0092-8674(00)00038-6
113. Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, Carano RA, et al. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci U S A (2010) 107:4287-92. doi:10.1073/pnas.0910609107
114. Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med (1996) 183:1287-92. doi:10.1084/jem.183.4.1287
115. Inaba K, Inaba M, Naito M, Steinman RM. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med (1993) 178:479-88. doi:10.1084/jem.178.2.479
116. Shurin GV, Tourkova IL, Chatta GS, Schmidt G, Wei S, Djeu JY, et al. Small rho GTPases regulate antigen presentation in dendritic cells. J Immunol (2005) 174:3394-400.
117. Amith SR, Jayanth P, Franchuk S, Finlay T, Seyrantepe V, Beyaert R, et al. Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cell Signal (2010) 22:314-24. doi:10.1016/j.cellsig.2009.09.038
118. Seyrantepe V, Iannello A, Liang F, Kanshin E, Jayanth P, Samarani S, et al. Regulation of phagocytosis in macrophages by neuraminidase 1. J Biol Chem (2010) 285:206-15. doi:10.1074/jbc.M109.055475
119. Watanabe Y, Shiratsuchi A, Shimizu K, Takizawa T, Nakanishi Y. Stimulation of phagocytosis of influenza virus-infected cells through surface desialylation of macrophages by viral neuraminidase. Microbiol Immunol (2004) 48:875-81. doi:10.1111/j.1348-0421.2004.tb03619.x
120. Sperandio M, Gleissner CA, Ley K. Glycosylation in immune cell trafficking. Immunol Rev (2009) 230:97-113. doi:10.1111/j.1600-065X.2009.00795.x
121. McEver RP. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol (2002) 14:581-6. doi:10.1016/S0955-0674(02)00367-8
122. Patel KD, Moore KL, Nollert MU, McEver RP. Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions. J Clin Invest (1995) 96:1887-96. doi:10.1172/JCI118234
123. Julien S, Grimshaw MJ, Sutton-Smith M, Coleman J, Morris HR, Dell A, et al. Sialyl-Lewis(x) on P-selectin glycoprotein ligand-1 is regulated during differentiation and maturation of dendritic cells: a mechanism involving the glycosyltransferases C2GnT1 and ST3Gal I. J Immunol (2007) 179:5701-10.
124. Pendl GG, Robert C, Steinert M, Thanos R, Eytner R, Borges E, et al. Immature mouse dendritic cells enter inflamed tissue, a process that requires E-and P-selectin, but not P-selectin glycoprotein ligand 1. Blood (2002) 99:946-56. doi:10.1182/blood.V99.3.946
125. Robert C, Fuhlbrigge RC, Kieffer JD, Ayehunie S, Hynes RO, Cheng G, et al. Interaction of dendritic cells with skin endothelium: a new perspective on immunosurveillance. J Exp Med (1999) 189:627-36. doi:10.1084/jem.189.4.627
126. Silva Z, Tong Z, Guadalupe Cabral M, Martins C, Castro R, Reis C, et al. Sialyl Lewis(x)-dependent binding of human monocyte-derived dendritic cells to selectins. Biochem Biophys Res Commun (2011) 409:459-64. doi:10.1016/j.bbrc.2011.05.026
127. Urzainqui A, Martinez del Hoyo G, Lamana A, de la Fuente H, Barreiro O, Olazabal IM, et al. Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J Immunol (2007) 179:7457-65.
128. Foxall C, Watson SR, Dowbenko D, Fennie C, Lasky LA, Kiso M, et al. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J Cell Biol (1992) 117:895-902. doi:10.1083/jcb.117.4.895
129. Marth JD, Grewal PK. Mammalian glycosylation in immunity. Nat Rev Immunol (2008) 8:874-87. doi:10.1038/nri2417
130. Kieffer JD, Fuhlbrigge RC, Armerding D, Robert C, Ferenczi K, Camphausen RT, et al. Neutrophils, monocytes, and dendritic cells express the same specialized form of PSGL-1 as do skin-homing memory T cells: cutaneous lymphocyte antigen. Biochem Biophys Res Commun (2001) 285:577-87. doi:10.1006/bbrc.2001.5230
131. Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood (1996) 88:3010-21.
132. Frommhold D, Ludwig A, Bixel MG, Zarbock A, Babushkina I, Weissinger M, et al. Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. J Exp Med (2008) 205:1435-46. doi:10.1084/jem.20070846
133. Semel AC, Seales EC, Singhal A, Eklund EA, Colley KJ, Bellis SL. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J Biol Chem (2002) 277:32830-6. doi:10.1074/jbc.M202493200
134. Woodard-Grice AV, McBrayer AC, Wakefield JK, Zhuo Y, Bellis SL. Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins. J Biol Chem (2008) 283:26364-73. doi:10.1074/jbc.M800836200
135. Rey-Gallardo A, Delgado-Martin C, Gerardy-Schahn R, Rodriguez-Fernandez JL, Vega MA. Polysialic acid is required for neuropilin-2a/b-mediated control of CCL21-driven chemotaxis of mature dendritic cells, and for their migration in vivo. Glycobiology (2011) 21:655-62. doi:10.1093/glycob/cwq216
136. Ridolfi R, Riccobon A, Galassi R, Giorgetti G, Petrini M, Fiammenghi L, et al. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med (2004) 2:27. doi:10.1186/1479-5876-2-27
137. Boog CJ, Neefjes JJ, Boes J, Ploegh HL, Melief CJ. Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen-presenting cells. Eur J Immunol (1989) 19:537-42. doi:10.1002/eji.1830190319
138. Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK. Human dendritic cell subsets for vaccination. J Clin Immunol (2005) 25:551-72. doi:10.1007/s10875-005-8216-7
139. Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest (2007) 117:1137-46. doi:10.1172/JCI31405
140. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature (1998) 392:245-52. doi:10.1038/32588
141. Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol (2011) 32:19-25. doi:10.1016/j.it.2010.10.002
142. Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol (2007) 25:267-96. doi:10.1146/annurev.immunol.25.022106.141609
143. Benencia F, Sprague L, McGinty J, Pate M, Muccioli M. Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination. J Biomed Biotechnol (2012) 2012:425476. doi:10.1155/2012/425476
144. Palucka K, Ueno H, Fay J, Banchereau J. Dendritic cells and immunity against cancer. J Intern Med (2011) 269:64-73. doi:10.1111/j.1365-2796.2010.02317.x
145. Strioga M, Schijns V, Powell DJ Jr, Pasukoniene V, Dobrovolskiene N, Michalek J. Dendritic cells and their role in tumor immunosurveillance. Innate Immun (2013) 19:98-111. doi:10.1177/1753425912449549
146. Saeland E, van Vliet SJ, Backstrom M, van den Berg VC, Geijtenbeek TB, Meijer GA, et al. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol Immunother (2007) 56:1225-36. doi:10.1007/s00262-006-0274-z
147. Napoletano C, Rughetti A, Agervig Tarp MP, Coleman J, Bennett EP, Picco G, et al. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res (2007) 67:8358-67. doi:10.1158/0008-5472.CAN-07-1035
148. Ishida A, Ohta M, Toda M, Murata T, Usui T, Akita K, et al. Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation. Proteomics (2008) 8:3342-9. doi:10.1002/pmic.200800039
149. Ohta M, Ishida A, Toda M, Akita K, Inoue M, Yamashita K, et al. Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9. Biochem Biophys Res Commun (2010) 402:663-9. doi:10.1016/j.bbrc.2010.10.079
150. Rughetti A, Pellicciotta I, Biffoni M, Backstrom M, Link T, Bennet EP, et al. Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. J Immunol (2005) 174:7764-72.